Primary Image

Generic Background Image

Clinical Trial

Neuromodulation and Neurorehabilitation for Treatment of Functional Deficits after mTBI plus PTSD

IRB Protocol Number STU00203773

Contact

Katie Kestner ckestner@sralab.org

Objective

The purpose of this study is to alleviate persisting attention deficits related to mild TBI and PTSD by treating the neurocognitive system of attention.

Who Can Participate

  • Mild TBI/concussive event 3 months to 10 years ago
  • Have co-occuring mild TBI and PTSD

Compensation

Provided

Age Range

18-80

Apply for this Trial

Your information will not be published.

All fields are required.

Featured Quote

More Studies

Brain-Based and Clinical Phenotyping of Pain Pharmacotherapy in Knee Osteoarthritis (PREDICT)

This is a clinical trial of people who have pain due to knee osteoarthritis at Northwestern University Feinberg School of Medicine in collaboration with Shirley Ryan 小恩雅. The study will last for about 20 weeks. 180 qualified participants will be randomly assigned in a 1:1:1 ratio (60 participants per group) to one of three treatment groups: duloxetine, celecoxib or placebo. Participants will have an X-ray, knee MRI, brain MRI, blood draws, pain sensitivity testing and will be asked to fill out questionnaires. The purpose of this study is to predict which participants will respond to the treatment.

read more
view all

Latest Updates

view all